Erlotinib Eg

Erlotinib Eg is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to cancer therapy.

Erlotinib Eg is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' This medication is part of a broader category of drugs known as tyrosine kinase inhibitors, which are used in cancer treatment.

Common effects of Erlotinib Eg may include skin rash, diarrhea, and fatigue. Some users may also experience appetite loss and nausea. These effects can vary from person to person, and it's important to monitor any changes in health while using this medication.

Erlotinib Eg should be handled with care, especially for those with pre-existing liver or kidney conditions. It is important to follow the advice of a healthcare professional regarding its use. Always store the medication as directed and keep it out of reach of children.

Erlotinib Eg may interact with certain medications, including those that are metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect how the body processes Erlotinib.